Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss

NCT: NCT06961305 · COMPLETED

NCT IDNCT06961305
StatusCOMPLETED
Start Date2021-08-10
Completion2022-06-02

Brief Summary

This post-marketing, prospective, multicentre, single-arm, open-label clinical investigation aimed to evaluate the safety, tolerability, and effectiveness of the injectable medical device Alexa Medium (based on cross-linked hyaluronic acid) for the correction of lip volume loss. Participants received one or two injections of the product, and effectiveness was assessed using the Global Aesthetic Improvement Scale (GAIS) and the Medicis Lip Fullness Scale (MLFS). Safety data were collected at each visit. The study demonstrated high effectiveness and safety, with most subjects achieving their personal aesthetic goals.

Frequently Asked Questions

What is A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss?

A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss is a clinical trial registered under NCT06961305. Current status: COMPLETED.

What is the status of NCT06961305?

The current status of NCT06961305 (A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss) is: COMPLETED.

When did A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss start?

A Post-Marketing Study of Alexa Medium for Сorrection of the Lips Volume Loss started on 2021-08-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.